Atopic Dermatitis is a very common skin disease affecting up to 20% of the general population. Dermatitis is characterized by a Th2 inflammatory response associated with epidermal barrier defects. Intense pruritis and colonization by Staphylococcus aureus exacerbate the inflammatory process and therefore the lesions.
StratiCELL has developed 3D in vitro skin models displaying atopic dermatitis features to study the efficacy of dermo-cosmetic active ingredients and skin care products to restore the skin barrier and reduce inflammation of atopic and sensitive skins.
